Search

everythinglearnresearchcommunity

for

Search:↓

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

A blood pressure drug, diltiazem, may also help treat influenza.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.